Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
Dr. Ido Nachmany works at Sheba Medical Center in Israel.


  • MD
  • Department of Surgery B
  • Hepato-pancreato-biliary surgery
  • robotic surgery
  • Hebrew
  • English


The director of Sheba’s General Surgery (Surgery B) Department, Dr. Nachmany has gained ample experience in complex liver, pancreas and bile duct operations, as well as adrenal, splenic and gastric resections.
A leader in his field, consistently ranked among the best doctors in Israel according to Forbes Magazine, Dr. Nachmany is a strong advocate of robotic and laparoscopic procedures which offer patients a shorter and less painful recovery process.


  • Director, Department of General Surgery (Surgery B)
  • Senior Lecturer, Sackler School of Medicine, Tel Aviv University
  • American Society of Transplant Surgeons (ASTS) Member
  • International Hepato-Pancreato-Biliary Association (IHPBA) Member

Education and Training

  • Abdominal Transplantation Fellowship at the TE Starzl Institute, University of Pittsburgh Medical Center, USA
  • Liver, Pancreatic and Biliary Surgery Fellowship at the TE Starzl Institute, UPMC, USA
  • General Surgery Residency, Tel Aviv Sourasky Medical Center, Israel
  • M.D., Sackler School of Medicine, Tel Aviv University, Israel

Board Certifications

  • Abdominal organ Transplantation (ASTS)
  • Hepato-Pancreato-Biliary Surgery (UPMC)
  • General Surgery (Israeli Board)


Buganim Y, Kalo E, Brosh R, Besserglick H, Nachmany I, Rais Y, Stambolsky P, Tang X, Milyavsky M, Shats I, Kalis M, Goldfinger N, Rotter V. Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction. Cancer Res. 2006;66(22):10750-9.

Lahat G, Ben Haim M, Nachmany I, Sever R, Blachar A, Nakache R, Klausner JM. Pancreatic incidentalomas: high rate of potentially malignant tumors. J Am Coll Surg. 2009;209(3):313-9.

Buganim Y, Solomon H, Rais Y, Kistner D, Nachmany I, Brait M, Madar S, Goldstein I, Kalo E, Adam N, Gordin M, Rivlin N, Kogan I, Brosh R, Sefadia-Elad G, Goldfinger N, Sidransky D, Kloog Y, Rotter V. p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways. Cancer Res. 2010;70(6):2274-84.

Lahat G, Sever R, Lubezky N, Nachmany I, Gerstenhaber F, Ben-Haim M, Nakache R, Koriansky J, Klausner JM. Pancreatic cancer: surgery is a feasible therapeutic option for elderly patients. World J Surg Oncol. 2011;9:10.

Groeschl RT, Nachmany I, Steel JL, Reddy SK, Glazer ES, de Jong MC, Pawlik TM, Geller DA, Tsung A, Marsh JW, Clary BM, Curley SA, Gamblin TC. Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg. 2012;214(5):769-77.

Gerstenhaber F, Grossman J, Lubezky N, Itzkowitz E, Nachmany I, Sever R, Ben-Haim M, Nakache R, Klausner JM, Lahat G. Pancreaticoduodenectomy in elderly adults: is it justified in terms of mortality, long-term morbidity, and quality of life? J Am Geriatr Soc. 2013;61(8):1351-7.

Nachmany I, Dvorchik I, Devera M, Fontes P, Demetris A, Humar A, Marsh JW. A validated model for predicting outcome after liver transplantation: implications on transplanting the extremely sick. Transpl Int. 2013;26(11):1108-15.

Nachmany I, Pencovich N, Zohar N, Ben-Yehuda A, Binyamin C, Goykhman Y, Lubezky N, Nakache R, Klausner JM. Laparoscopic versus open liver resection for metastatic colorectal cancer. Eur J Surg Oncol. 2015;41(12):1615-20.

Nachmany I, Pencovich N, Zohar N, Goykhman Y, Lubezky N, Nakache R, Klausner JM. Resection of colorectal liver metastases in the elderly-Is it justified? J Surg Oncol. 2016;113(5):485-8.

Nachmany I, Pencovich N, Ben-Yehuda A, Lahat G, Nakache R, Goykhman Y, Lubezky N, Klausner JM. Laparoscopic Distal Pancreatectomy: Learning Curve and Experience in a Tertiary Center. J Laparoendosc Adv Surg Tech A. 2016;26(6):470-4.

Osher E, Scapa E, Klausner J, Greenman Y, Tordjman K, Melhem A, Nachmany I, Sofer Y, Geva R, Blachar A, Stern N, Santo E. Pancreatic incidentaloma: differentiating nonfunctioning pancreatic neuroendocrine tumors from intrapancreatic accessory spleen. Endocr Pract. 2016;22(7):773-9.

Lahat G, Lubezky N, Gerstenhaber F, Nizri E, Gysi M, Rozenek M, Goichman Y, Nachmany I, Nakache R, Wolf I, Klausner JM. Number of evaluated lymph nodes and positive lymph nodes, lymph node ratio, and log odds evaluation in early-stage pancreatic ductal adenocarcinoma: numerology or valid indicators of patient outcome? World J Surg Oncol. 2016;14(1):254.

Weiser R, Pencovich N, Mlynarsky L, Berliner-Senderey A, Lahat G, Santo E, Klausner JM, Nachmany I. Management of endoscopic retrograde cholangiopancreatography-related perforations: Experience of a tertiary center. Surgery. 2017;161(4):920-9.

Lubezky N, Papoulas M, Lessing Y, Gitstein G, Brazowski E, Nachmany I, Lahat G, Goykhman Y, Ben-Yehuda A, Nakache R, Klausner JM. Solid pseudopapillary neoplasm of the pancreas: Management and long-term outcome. Eur J Surg Oncol. 2017;43(6):1056-60.

Barenboim A, Lahat G, Geva R, Nachmany I, Nakache R, Goykhman Y, Brazowski E, Rosen G, Isakov O, Wolf I, Klausner JM, Lubezky N. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis. Eur J Surg Oncol. 2018;44(10):1619-23.

Nachmany I, Bogoch Y, Friedlander-Malik G, Amar O, Bondar E, Zohar N, Hantisteanu S, Fainaru O, Lubezky N, Klausner JM, Pencovich N. The transcriptional profile of circulating myeloid derived suppressor cells correlates with tumor development and progression in mouse. Genes Immun. 2019;20(7):589-98.

Lessing Y, Pencovich N, Nevo N, Lubezky N, Goykhman Y, Nakache R, Lahat G, Klausner JM, Nachmany I. Early reoperation following pancreaticoduodenectomy: impact on morbidity, mortality, and long-term survival. World J Surg Oncol. 2019;17(1):26.

Pencovich N, Houli R, Lubezky N, Goykhman Y, Nakache R, Klausner JM, Nachmany I. R1 resection of colorectal liver metastasis - What is the cost of marginal resection? J Surg Oncol. 2019;119(3):347-54.

Nachmany I, Bogoch Y, Sivan A, Amar O, Bondar E, Zohar N, Yakubovsky O, Fainaru O, Klausner JM, Pencovich N. CD11b+Ly6G+ myeloid-derived suppressor cells promote liver regeneration in a murine model of major hepatectomy. FASEB J. 2019;33(5):5967-78.

Barenboim A, Lahat G, Nachmany I, Nakache R, Goykhman Y, Geva R, Osher E, Scapa E, Wolf I, Orbach L, Brazowski E, Isakov O, Klausner JM, Lubezky N. Resection Versus Observation of Small Asymptomatic Nonfunctioning Pancreatic Neuroendocrine Tumors. J Gastrointest Surg. June 2019. doi:10.1007/s11605-019-04285-y. [Epub ahead of print]

Meyerovich G, Goykhman Y, Nakache R, Nachmany I, Lahat G, Shibolet O, Menachem Y, Katchman H, Wolf I, Geva R, Klausner JM, Lubezky N. Resection vs Transplant Listing for Hepatocellular Carcinoma: An Intention-to-Treat Analysis. Transplant Proc. 2019;51(6):1867-73.

Neeman U, Lahat G, Goykhman Y, Geva R, Peles-Avraham S, Nachmany I, Nakache R, Klausner JM, Lubezky N. Prognostic significance of pancreatic fistula and postoperative complications after pancreaticoduodenectomy in patients with pancreatic ductal adenocarcinoma. Surgeon. August 2019. doi:10.1016/j.surge.2019.07.003. [Epub ahead of print]

Barash Y, Klang E, Lux A, Konen E, Horesh N, Pery R, Zilka N, Eshkenazy R, Nachmany I, Pencovich N. Artificial intelligence for identification of focal lesions in intraoperative liver ultrasonography. Langenbecks Arch Surg. 2022 Sep 7.

Younis M, Pencovich N, El-On R, Lubezky N, Goykhman Y, Phillips A, Nachmany I. Surgical Treatment for Choledocholithiasis Following Repeated Failed Endoscopic Retrograde Cholangiopancreatography. J Gastrointest Surg. 2022 Jun;26(6):1233-1240.

Nevo N, Pencovich N, Lessing Y, Lasmanovich R, Barnes S, Lahat G, Nachmany I, Klausner JM. Preoperative biopsy for suspected adenocarcinoma of the pancreatic head: yield and complications. Minerva Surg. 2022 Apr;77(2):118-123

Silverman J, Pencovich N, Mayer C, Volkov A, Eshkenazi R, Nachmany I. Giant leiomyosarcoma of the inferior vena cava necessitating extended liver resection: A case report and review of the literature. J Surg Case Rep. 2021 Jun 22;2021(6).

Pencovich N, Lachiani M, Phillips A, Santo E, Nachmany I. Serum Amylase Levels is a Predictor for Negative Endoscopic Retrograde Cholangiopancreatography for Suspected Common Bile Duct Stones. Surg Laparosc Endosc Percutan Tech. 2021 Feb 2;31(5):528-532.

Anteby R, Klang E, Horesh N, Nachmany I, Shimon O, Barash Y, Kopylov U, Soffer S. Deep learning for noninvasive liver fibrosis classification: A systematic review. Liver Int. 2021 Oct;41(10):2269-2278.

Pencovich N, Nevo N, Weiser R, Bonder E, Bogoch Y, Nachmany I Postoperative Rise of Circulating Mitochondrial DNA Is Associated with Inflammatory Response in Patients following Pancreaticoduodenectomy. Eur Surg Res. 2021;62(1):18-24.

Hashavia E, Goldstein AL, Nachmany I, Shimonov A, Klausner JM, Soffer D. Definitive Repair of Injuries to the Liver During Initial Trauma Laparotomy. Am Surg. 2021 Aug;87(8):1299-1304.

Fong Y, Buell JF, Collins J, Martinie J, Bruns C, Tsung A, Clavien PA, Nachmany I, Edwin B, Pratschke J, Solomonov E, Koenigsrainer A, Giulianotti PC. Applying the Delphi process for development of a hepatopancreaticobiliary robotic surgery training curriculum. Surg Endosc. 2020 Oct;34(10):4233-4244.

Gilad O, Rabinowich L, Levy S, Gotlieb N, Lubezky N, Goykhman Y, Nachmany I, Katz P, Shibolet O, Katchman H. Metabolic and Renal Effects of Mammalian Target of Rapamycin Inhibitors Treatment After Liver Transplantation: Real-Life Single-Center Experience. Transplant Proc. 2021 Jan-Feb;53(1):221-227.

Orbach L, Nachmany I, Goykhman Y, Lahat G, Yossepowitch O, Beri A, Ben-Gal Y, Klausner JM, Lubezky N. Surgical Approach to Abdominal Tumors Involving the Inferior Vena Cava. Isr Med Assoc J. 2020 Jun;22(6):364-368.

Golan T, Barenboim A, Lahat G, Nachmany I, Goykhman Y, Shacham-Shmueli E, Halpern N, Brazowski E, Geva R, Wolf I, Goldes Y, Ben-Haim M, Klausner JM, Lubezky N. Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer. Ann Surg Oncol. 2020 Oct;27(10):3963-3970.

Pencovich N, Orbach L, Lessing Y, Elazar A, Barnes S, Berman P, Blachar A, Nachmany I, Sagie B. Palliative bypass surgery for patients with advanced pancreatic adenocarcinoma: experience from a tertiary center. World J Surg Oncol. 2020 Apr 1;18(1):63.

Cohen SJ, Papoulas M, Graubardt N, Ovdat E, Loewenstein S, Kania-Almog J, Pasmanik-Chor M, Brazowski E, Cagnano E, Nachmany I, Lahat G, Klausner JM, Lubezky N. Micro-RNA Expression Patterns Predict Metastatic Spread in Solid Pseudopapillary Neoplasms of the Pancreas. Front Oncol. 2020 Mar 13;10:328.

Request a consultation

Sheba Medical Center provides innovative, personalized medical care to patients from around the world. We are the largest, most comprehensive hospital in the Middle East and dedicated to providing advanced and compassionate medicine for everyone.

We welcome all cases, including the rarest and the most challenging. Our medical teams collaborate to provide the best possible health outcomes. From your initial inquiry through the long-term follow-up care, we are here for you.

Request a consultation and a Sheba Case Manager will contact you shortly: